Lauren M. Rosati

1.6k total citations
46 papers, 1.1k citations indexed

About

Lauren M. Rosati is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Lauren M. Rosati has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 17 papers in Cancer Research and 13 papers in Genetics. Recurrent topics in Lauren M. Rosati's work include Pancreatic and Hepatic Oncology Research (36 papers), Cancer Genomics and Diagnostics (17 papers) and Glioma Diagnosis and Treatment (13 papers). Lauren M. Rosati is often cited by papers focused on Pancreatic and Hepatic Oncology Research (36 papers), Cancer Genomics and Diagnostics (17 papers) and Glioma Diagnosis and Treatment (13 papers). Lauren M. Rosati collaborates with scholars based in United States, Japan and Canada. Lauren M. Rosati's co-authors include Joseph M. Herman, Daniel A. Laheru, Amy Hacker‐Prietz, Lei Zheng, Avani Satish Dholakia, Timothy M. Pawlik, Christopher L. Wolfgang, Aaron T. Wild, Matthew J. Weiss and Siva P. Raman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Lauren M. Rosati

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren M. Rosati United States	16	874	459	282	206	201	46	1.1k
Avani Satish Dholakia United States	10	806 0.9×	375 0.8×	290 1.0×	193 0.9×	172 0.9×	25	952
Yeon‐Sil Kim South Korea	22	546 0.6×	705 1.5×	132 0.5×	140 0.7×	454 2.3×	110	1.6k
Mariangela Massaccesi Italy	20	405 0.5×	563 1.2×	101 0.4×	115 0.6×	286 1.4×	92	1.2k
Binglin Yue United States	16	320 0.4×	335 0.7×	139 0.5×	54 0.3×	212 1.1×	41	857
Barbara Bachtiary Switzerland	18	216 0.2×	259 0.6×	257 0.9×	205 1.0×	242 1.2×	43	1.0k
Richard J. Cassidy United States	19	405 0.5×	502 1.1×	138 0.5×	128 0.6×	282 1.4×	50	934
L. Caravatta Italy	19	418 0.5×	325 0.7×	88 0.3×	72 0.3×	284 1.4×	71	886
Florian Würschmidt Germany	19	330 0.4×	500 1.1×	316 1.1×	51 0.2×	129 0.6×	49	1.0k
Kimberly S. Corbin United States	18	368 0.4×	745 1.6×	380 1.3×	52 0.3×	290 1.4×	79	1.3k
D.A. Clump United States	19	460 0.5×	413 0.9×	106 0.4×	66 0.3×	306 1.5×	47	1.1k

Countries citing papers authored by Lauren M. Rosati

Since Specialization

Citations

This map shows the geographic impact of Lauren M. Rosati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren M. Rosati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren M. Rosati more than expected).

Fields of papers citing papers by Lauren M. Rosati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren M. Rosati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren M. Rosati. The network helps show where Lauren M. Rosati may publish in the future.

Co-authorship network of co-authors of Lauren M. Rosati

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren M. Rosati. A scholar is included among the top collaborators of Lauren M. Rosati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren M. Rosati. Lauren M. Rosati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hill, Colin, Rose Parkinson, Elizabeth M. Jaffee, et al.. (2024). Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 121(4). 930–941. 5 indexed citations

Hill, Colin, Lauren M. Rosati, Hao Wang, et al.. (2022). Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial. Practical Radiation Oncology. 12(6). 511–523. 10 indexed citations

Rosati, Lauren M., et al.. (2020). Early Anticoagulation or Antiplatelet Therapy Is Critical in Craniocervical Artery Dissection: Results from the COMPASS Registry. Cerebrovascular Diseases. 49(4). 369–374. 5 indexed citations

Iyer, Renuka, et al.. (2018). Cholangiocarcinoma: Treatment, Outcomes, and Nutrition Overview for Oncology Nurses. Clinical journal of oncology nursing. 22(4). E97–E102. 6 indexed citations

Blair, Alex B., Lauren M. Rosati, Neda Rezaee, et al.. (2018). Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy. Surgery. 163(5). 1090–1096. 34 indexed citations

Yamamoto, Kimiyo N., Shinichi Yachida, Akira Nakamura, et al.. (2017). Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling. Cancer Research. 77(12). 3325–3335. 9 indexed citations

Ryan, John F., Vincent P. Groot, Lauren M. Rosati, et al.. (2017). Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective. Annals of Surgical Oncology. 25(1). 280–289. 25 indexed citations

Rao, Avani D., Stephanie Coquia, Christine G. Gourin, et al.. (2017). Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers. Radiotherapy and Oncology. 126(1). 96–99. 11 indexed citations

Kohutek, Zachary A., Lauren M. Rosati, Justin Poling, et al.. (2017). An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course. Molecular Case Studies. 3(4). a001701–a001701. 6 indexed citations

10.

Rosati, Lauren M., Justin Poling, Amy Hacker‐Prietz, et al.. (2017). A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review. Oncotarget. 8(59). 100942–100950. 4 indexed citations

11.

Rao, Avani D., Elizabeth A. Sugar, Daniel T. Chang, et al.. (2016). Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer. Practical Radiation Oncology. 6(6). 417–424. 16 indexed citations

12.

Myrehaug, Sten, Arjun Sahgal, Suzanne Russo, et al.. (2016). Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions. Expert Review of Anticancer Therapy. 16(5). 523–530. 26 indexed citations

13.

Narang, Amol, Lauren M. Rosati, Omar Y. Mian, et al.. (2016). Neoadjuvant Stereotactic Body Radiation Therapy Dosimetric Parameters Predict for Pathologic Outcomes and Survival in Pancreas Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 96(2). E213–E214. 1 indexed citations

14.

Fan, Katherine, Aaron T. Wild, Vivek Gowdra Halappa, et al.. (2016). Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization. Contemporary Clinical Trials. 50. 143–149. 21 indexed citations

15.

Rosati, Lauren M., et al.. (2015). Stereotactic Body Radiation for Pancreatic Cancer: Results of an International Survey of Practice Patterns. International Journal of Radiation Oncology*Biology*Physics. 93(3). E132–E132. 5 indexed citations

16.

Wild, Aaron T., Joseph M. Herman, Avani Satish Dholakia, et al.. (2015). Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 94(3). 571–579. 167 indexed citations

17.

Saeed, Ali, Lauren M. Rosati, Amol Narang, et al.. (2015). Elevated Absolute Monocyte Count, Absolute Neutrophil Count, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 93(3). E157–E157. 3 indexed citations

18.

Rosati, Lauren M., Zhi Cheng, S.P. Robertson, et al.. (2015). Patient- versus physician-reported outcomes in patients enrolled in a prospective study involving stereotactic body radiation therapy in unresectable or recurrent pancreatic cancer.. Journal of Clinical Oncology. 33(29_suppl). 84–84. 1 indexed citations

19.

Wang, Jingya, Amol Narang, Elizabeth A. Sugar, et al.. (2015). Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Annals of Surgical Oncology. 22(S3). 1100–1106. 27 indexed citations

20.

Franke, Aaron J, Lauren M. Rosati, Timothy M. Pawlik, Rachit Kumar, & Joseph M. Herman. (2014). The Role of Radiation Therapy in Pancreatic Ductal Adenocarcinoma in the Neoadjuvant and Adjuvant Settings. Seminars in Oncology. 42(1). 144–162. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact